OverviewSuggest Edit

Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. It develops ImmTAC (Immune Mobilizing Monoclonal TCRs Against Cancer) molecules, ImmTAV and ImmTAB (Immune Mobilizing Monoclonal TCRs Against Virus or Bacteria) molecules, and ImmTAAI (Immune Mobilizing Monoclonal TCRs Against Autoimmune Disease) molecules. The company uses human TCRs to overcome the limitations of a natural immune system and current therapeutic approaches through engineering bispecific.

TypePublic
Founded2008
HQMilton, GB
Websiteimmunocore.com
Employee Ratings3

Latest Updates

Employees (est.) (Dec 2020)291
Revenue (FY, 2018)£24.3 M(+67%)
Share Price (Feb 2021)$52.9 (+4%)
Cybersecurity ratingAMore

Key People/Management at Immunocore

Bahija Jallal

Bahija Jallal

Chief Executive Officer
Brian di Donato

Brian di Donato

Chief Financial Officer and Head of Strategy
Frankie Webster

Frankie Webster

Chief People Officer
Annelise Vuidepot

Annelise Vuidepot

Chief Technology Officer (CTO) & Head of Pipeline and Platform Research
John Bell

John Bell

Chairman
Andrew Hooker

Andrew Hooker

Vice President of Chemistry, Manufacturing and Controls (CMC)
Show more

Immunocore Office Locations

Immunocore has offices in Milton, Conshohocken and Rockville
Milton, GB (HQ)
92 Park Dr
Conshohocken, PA, US
181 Washington St #200
Rockville, MD, US
2273 Research Blvd #220
Show all (3)

Immunocore Financials and Metrics

Immunocore Revenue

Immunocore's revenue was reported to be £24.28 m in FY, 2018
GBP

Revenue (FY, 2018)

24.3m

Gross profit (FY, 2018)

(59.3m)

Gross profit margin (FY, 2018), %

(244.3%)

Net income (FY, 2018)

(71.6m)

EBIT (FY, 2018)

(93.5m)

Market capitalization (10-Feb-2021)

2.2b

Closing stock price (10-Feb-2021)

52.9

Cash (31-Dec-2018)

124.4m

EV

2.1b
Immunocore's current market capitalization is $2.2 b.
GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

2.0m6.4m14.3m17.3m14.6m24.3m

Revenue growth, %

212%

Cost of goods sold

83.6m

Gross profit

(59.3m)
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

7.2m3.4m5.0m3.8m2.3m16.3m50.9m219.7m134.4m82.9m124.4m

Accounts Receivable

1.1m1.2m2.0m1.6m307.3k203.0k186.0k1.0m258.0k4.4m

Inventories

Current Assets

7.2m4.5m6.1m5.8m3.9m18.0m54.3m228.7m191.2m143.5m171.2m
GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(3.7m)(5.6m)16.8m(23.1m)(48.9m)

Cash From Operating Activities

11.3m40.3m(22.4m)(36.9m)(60.9m)(16.6m)

Cash From Investing Activities

58.0m

Cash From Financing Activities

3.0m404.0k197.7m96.0k19.1m101.0k
GBPFY, 2008

Financial Leverage

1 x
Show all financial metrics

Immunocore Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Immunocore Online and Social Media Presence

Embed Graph

Immunocore News and Updates

British biotech firm Immunocore opts for New York float

Cancer biotech firm Immunocore is looking to list on the Nasdaq rather than London as it aims to raise up The post British biotech firm Immunocore opts for New York float appeared first on CityAM.

Immunocore Frequently Asked Questions

  • When was Immunocore founded?

    Immunocore was founded in 2008.

  • Who are Immunocore key executives?

    Immunocore's key executives are Bahija Jallal, Brian di Donato and Frankie Webster.

  • How many employees does Immunocore have?

    Immunocore has 291 employees.

  • What is Immunocore revenue?

    Latest Immunocore annual revenue is £24.3 m.

  • What is Immunocore revenue per employee?

    Latest Immunocore revenue per employee is £83.4 k.

  • Who are Immunocore competitors?

    Competitors of Immunocore include LogicBio Therapeutics, F-star Biotechnology and KemPharm.

  • Where is Immunocore headquarters?

    Immunocore headquarters is located at 92 Park Dr, Milton.

  • Where are Immunocore offices?

    Immunocore has offices in Milton, Conshohocken and Rockville.

  • How many offices does Immunocore have?

    Immunocore has 3 offices.